I now have sufficient information from authoritative textbook sources to provide a comprehensive answer. Let me synthesize everything.
Clinical Case Analysis: 7-year-old girl with acute meningeal syndrome
1. Preliminary Diagnosis
Serous (viral/aseptic) meningitis, acute course, moderate severity
Most likely etiology: Enteroviral meningitis (echovirus/coxsackievirus)
Justification:
| Feature | This patient |
|---|
| Age / season | Child, summer/fall (pond swimming) |
| Onset | Acute febrile illness (38.5°C) |
| Symptoms | Headache, vomiting, hyperesthesia, neck stiffness |
| Meningeal signs | Neck rigidity (4 finger-breadths), Kernig +, upper Brudzinski + |
| CSF pressure | Elevated (300 mm H₂O) |
| CSF appearance | Transparent (clear) — distinguishes from bacterial |
| CSF cytosis | 500 cells/μL — pleocytosis |
| CSF differential | Lymphocytic predominance (85%) — hallmark of viral meningitis |
| CSF protein | 0.33 g/L — mildly elevated (normal range) |
| CSF glucose | 3.5 mmol/L — normal (distinguishes from TB and bacterial) |
| Blood count | Leukocytes 6.0×10⁹/L, lymphocytosis (62%) — no bacterial shift |
| ESR | 10 mm/h — normal |
The epidemiological history of swimming in a pond is characteristic of enteroviral infection transmission (fecal-oral route, contaminated water).
The oropharyngeal findings (moderate hyperemia, posterior pharyngeal wall granularity) with normal tonsils suggest a preceding or concurrent enteroviral upper respiratory/pharyngeal infection, which is classic.
— Goldman-Cecil Medicine, p. 4009–4010: "Enteroviruses account for more than 60% of viral meningitides... spread predominantly by the fecal-oral route... CSF shows predominantly lymphocytic pleocytosis, normal glucose, mildly elevated protein."
2. Differential Diagnosis
A. Bacterial (Purulent) Meningitis — Against this diagnosis
| Parameter | Viral (this patient) | Bacterial |
|---|
| CSF appearance | Clear, transparent | Turbid/cloudy |
| Cytosis | 500 cells, 85% lymphocytes | Thousands of cells, >80% neutrophils |
| CSF glucose | Normal (3.5 mmol/L) | Markedly reduced (<2.2 mmol/L) |
| CSF protein | 0.33 g/L (mildly ↑) | Markedly elevated (>1 g/L) |
| Blood WBC | 6.0×10⁹/L, lymphocytosis | Marked leukocytosis with neutrophilia |
| ESR | 10 mm/h | Markedly elevated |
| Skin | No petechiae | Petechial rash (meningococcal) |
Conclusion: CSF profile is incompatible with bacterial meningitis.
B. Tuberculous Meningitis — Against
- TB meningitis has a subacute/chronic onset (weeks), not acute
- CSF glucose is low in TB meningitis (hypoglycorrhachia)
- No TB contact history; no lymphadenopathy mentioned
- This patient: normal glucose, acute onset
C. Bacterial Meningitis (Early phase) — Consider
- In the first 24–48 h of enteroviral meningitis, up to 50% of patients show neutrophilic predominance; but this patient already has 85% lymphocytes, making early bacterial meningitis very unlikely
- No gram-positive/negative organisms on CSF analysis mentioned
D. Meningococcemia with Meningitis — Against
- No petechial/hemorrhagic skin rash
- No marked neutrophilia in blood
- CSF is clear, not turbid
E. Leptospiral / Water-Borne Bacterial Meningitis — Consider
- Leptospirosis can be acquired from contaminated water; can cause aseptic meningitis
- However, leptospirosis typically presents with biphasic illness, jaundice, myalgia, conjunctival suffusion — none of these are present here
- Must be excluded by serology given the epidemiological history
— Goldman-Cecil Medicine, p. 4010: "Epidemiologic considerations and clinical findings aid in distinguishing leptospiral, Lyme Borrelia, and syphilitic meningitis, whereas hypoglycorrhachia suggests tuberculous and cryptococcal meningitis."
3. Investigation Plan
Mandatory (confirmatory):
| Investigation | Purpose |
|---|
| CSF PCR (enterovirus, HSV-1, HSV-2, EBV, CMV) | Identify causative virus; gold standard (sensitivity 85–100%) |
| CSF viral culture | Backup to PCR (sensitivity 65–75%, takes 4–8 days) |
| Repeat CBC with differential | Monitor for bacterial superinfection or shift to neutrophilia |
| Blood culture ×2 | Exclude bacteremia |
| CSF Gram stain and bacterial culture | Definitively exclude bacterial meningitis |
| CSF protein, glucose (repeat) | Monitor dynamics |
| Blood glucose simultaneously with CSF glucose | Ensure proper CSF/blood glucose ratio interpretation |
Etiological workup (epidemiological context — pond exposure):
| Investigation | Purpose |
|---|
| Leptospira serology (MAT or IgM ELISA) | Exclude leptospirosis (water exposure) |
| Enterovirus serology (paired sera) | Confirm seroconversion if PCR negative |
| Throat and rectal swabs for enterovirus culture | Enteroviruses shed in stool/throat; supports diagnosis |
Additional:
| Investigation | Purpose |
|---|
| MRI brain (if neurological deterioration) | Exclude encephalitis, abscess, hydrocephalus |
| Biochemical panel (ALT, AST, bilirubin, creatinine) | Exclude hepatic involvement (leptospirosis) |
| Urinalysis | Exclude renal involvement |
| EEG (if seizures) | Rule out encephalitic component |
4. Treatment Plan
Hospitalization: Required (neurology/infectious disease ward)
Regimen (supportive — since this is viral):
Bed rest: During the acute febrile period.
Antipyretics / Analgesics:
- Ibuprofen 10 mg/kg/dose every 6–8 hours OR paracetamol 15 mg/kg/dose every 4–6 hours — for fever and headache
Dehydration therapy (to reduce intracranial pressure):
- Furosemide 1–2 mg/kg IV/IM OR
- Acetazolamide 10–15 mg/kg/day (reduces CSF production)
- Careful fluid restriction to 75% of maintenance if signs of SIADH
Symptomatic:
- Antiemetics (metoclopramide 0.1 mg/kg/dose IV if vomiting is severe)
- Analgesics for headache
Antiviral therapy:
- No specific antiviral approved for enteroviral meningitis
- If HSV meningitis cannot be excluded: Acyclovir 500 mg/m²/dose IV q8h × 14–21 days pending PCR results
- Once PCR confirms enterovirus, acyclovir can be discontinued
Do NOT administer:
- Antibiotics are not indicated (unless bacterial meningitis cannot be excluded pending cultures — empirical antibiotics may be started and stopped once cultures negative)
- Corticosteroids are NOT indicated for viral meningitis (indicated only for bacterial meningitis)
— Goldman-Cecil Medicine, p. 4010: "Most cases of viral meningitis are self-limited and require only supportive treatment."
— Textbook of Family Medicine: "Children seem to recover within 1 to 2 weeks."
Prognosis: Excellent. Full recovery expected within 1–2 weeks.
5. Prophylaxis and Anti-Epidemic Measures
Regarding the patient:
- Isolation: Standard/contact precautions during hospitalization (enteroviruses shed in feces and respiratory secretions)
- Mandatory notification to public health authorities (infectious disease reporting)
- Stool and throat swabs from close contacts if outbreak suspected
Environmental / Community measures:
- Ban or warning against swimming in the implicated pond pending water quality testing
- Sanitary-epidemiological investigation of the water body — test for enteroviral contamination
- Water quality monitoring (coliform/enteroviral indices)
- Notify local public health/sanitary authority (Rospotrebnadzor or equivalent)
Personal preventive measures:
- Avoid swimming in open water bodies of unknown quality, especially during summer outbreaks
- Hand hygiene (soap and water — essential, as enteroviruses are resistant to alcohol-based gels at standard concentrations)
- Fecal-oral route prevention: food hygiene, handwashing after toilet use
Vaccination:
- No licensed vaccine available against enteroviruses in most countries (EV71 vaccine available in some Asian countries)
- Ensure routine childhood immunizations are up to date (includes poliovirus, mumps — both causes of aseptic meningitis)
Contact tracing:
- Identify other children/adults who swam in the same pond
- Monitor contacts for 7–14 days (enteroviral incubation 2–7 days, up to 14 days)
- If additional cases found — declare local outbreak
Summary diagnosis: Acute serous (viral/enteroviral) meningitis, moderate severity, in a 7-year-old, most likely acquired via contaminated recreational water. The CSF profile (clear fluid, lymphocytic pleocytosis, normal glucose, mildly elevated protein) is the definitive distinguishing feature from bacterial meningitis. Management is primarily supportive with close monitoring; antiviral therapy (acyclovir) is held pending PCR to exclude HSV.